// App-Quantinova.ai

1012 : ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome

Researchers

Presenter

  • Jasmijn de Rooij

Principal Investigators

  • Eva Beuling

  • Maarten Fornerod

  • C. Michel Zwaan

  • Askar Obulkasim

  • Andre Baruchel

  • Jan Trka

  • Dirk Reinhardt

  • Edwin Sonneveld

  • Martin Zimmermann

  • Rob Pieters

  • Marry van den Heuvel-Eibrink

Medical Centers

  • Dutch Childhood Oncology Group, The Hague, Netherlands.

  • Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Department of Hematology, Hopital Necker, Paris, France

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Princess Maxima Center for Pediatric Oncology, Netherlands

  • Biochemistry, Erasmus MC, Rotterdam, Netherlands

  • AML-BFM Study Group, Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany

Locations

  • France

  • Czech Republic

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Afadin, Adherens Junction Formation Factor

  • Breakpoint Cluster Region

  • Promyelocytic Leukemia

  • Dipeptidase 1

  • ETV6-RUNX1

  • Histone-lysine N-methyltransferase 2A

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved